Novi Sad Court Bans the Sale of Krka's Zyllt Again
Novo Mesto, 2 November - The Novi Sad Commercial Court re-issued a temporary injunction on the imports and sales of pharma company Krka's Zyllt drug in Serbia. The court had already issued an injunction in June, but its decision was overruled by the Higher Commercial Court in Belgrade in July.
The rest of this news item is available to subscribers.
The news item consists of 679 characters (without spaces) or 121 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.